mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |